Experimental pain in the groin may refer into the lower abdomen Implications to clinical assessments Drew, M. K.; Palsson, Thorvaldur Skuli; Hirata, Rogerio Pessoto; Izumi, Masashi; Lovell, G.; Welvaert, M.; Chiarelli, P.; Osmotherly, P. G.; Graven-Nielsen, Thomas ABSTRACT 1 Objectives: To investigate the effects of experimental adductor pain on the pain referral pattern, 2 mechanical sensitivity and muscle activity during common clinical tests. 3 4 Design: Repeated-measures design 5 6 Methods: In two separate sessions, 15 healthy males received a hypertonic (painful) and isotonic 7 (control) saline injection to either the adductor longus (AL) tendon to produce experimental groin 8 pain or into the rectus femoris (RF) tendon as a painful control. Pain intensity was recorded on a 9 visual analogue scale (VAS) with pain distribution indicated on body maps. Pressure pain thresholds 10 (PPT) were assessed bilaterally in the groin area. Electromyography (EMG) of relevant muscles was 11 recorded during six provocation tests. PPT and EMG assessment were measured before, during and 12 after experimental pain. 13 14 Results: Hypertonic saline induced higher VAS scores than isotonic saline (p<0.001), and a local pain 15 distribution in 80% of participants. A proximal pain referral to the lower abdominal region in 33% 16 (AL) and 7% (RF) of participants. Experimental pain (AL and RF) did not significantly alter PPT 17 values or the EMG amplitude in groin or trunk muscles during provocation tests when forces were 18 matched with baseline. 19 20
Introduction 26
The prevalence of hip and groin pain in athletes is generally high with a career prevalence of 45% 27 reported in professional Australian football players 1 and a high incidence in sports such as football 2 28 and ice hockey. 3 Adductor-related groin pain is characterised as pain on resisted adduction and pain 29 on palpation of the adductor longus muscle. 4 In contrast, abdominal symptoms present with pain on 30 resisted trunk flexion and pain on palpation of the rectus abdominis distal enthesis. 5 Yet 31 characteristics of groin pain per se are poorly understood with few reports of pain referral patterns and 32 clinical symptomatology. Pain referral patterns are typically semi-(referring distally) or bi-directional 33 (referring both distally and proximally) with referred pain distributions extending to neighbouring 34 vertebral segments that are supplying the painful muscle or tendon. 6 Clinically, pain in both the 35 adductor and abdominal area is associated with longer recovery times compared to a single site. 7 The 36 role of pain referral patterns has not previously been examined and may present a plausible alternate 37 hypothesis to co-existing pain locations 5, 8-10 in this region. That is, abdominal pain may present 38 clinically as a result of referred pain from the adductor region. If this is true, it challenges using pain 39 location alone as diagnostic criteria in either classifying patients into entities or to specific 40 pathoanatomical tissue diagnoses. 41
The experiment had a randomized, single-blinded, balanced-crossover, repeated-measures design 81 conducted in two sessions within one week. Randomisation was achieved through the selection of one 82 of 16 identical envelopes by an experimenter (blinded to the injector and experimenters) containing 83 one of all 16 possible order combinations of injection site, side, and injection site. Blinding was 84 achieved through unlabelled, identical pre-prepared syringes prior to the experimenters entering the 85 room. The participants were not advised of the order of injections at any stage throughout the 86 procedure. 20 Experimental groin pain and a painful control condition outside the groin area were 87 evaluated. Clinical provocation tests with recordings of the muscle activity and assessment of the 88 pressure pain sensitivity were administered at baseline, during and after (post-pain) experimental pain 89 with participant lying supine on a plinth. Prior to baseline testing, all participants were familiarised 90 with the experimental procedure and confirmed to be pain-free prior to commencing the study. The 91 post-pain state was defined as five minutes after the cessation of experimental pain. 92
93
The participants participated in two sessions and received one hypertonic and one isotonic saline 94 injection each session, one in each side of the same site (AL or RF) during each session. The alternate 95 site was injected in the following session. The order of the saline type (hypertonic or isotonic) and 96 site (AL or RF) and side (left or right) was randomised in a balanced way. Groin pain was induced by 97 injecting sterile hypertonic saline (1 ml, 5.8%) into the adductor longus (AL) tendon with isotonic 98 saline (1 ml, 0.9%) injected as a non-painful control into the same anatomical site on the contralateral 99 side within the same session. As a positive (painful) control injection outside the groin area, the 100 proximal tendon of the long head of the rectus femoris (RF) muscle was injected in a separate session. 101
The same volume of hypertonic or isotonic saline was injected into the control site as designated by 102 the randomisation. Participants and injector were blinded to saline type administered. All injections 103 were given by an orthopaedic surgeon (MI). After a standard disinfection protocol, the injections were 104
given over the duration of approximately 10 seconds using a 2-ml plastic syringe with a disposable 105 needle (27G). Pre-defined anatomical landmarks for injection sites for AL and RF tendons were 106 utilised. The location, depth and alignment of all injection sites were confirmed by real time 107 ultrasound (US) imaging (Acuson 128XP10, NativeTM). The AL tendon was identified using a 108 method previously described. 18 Both the AL and RF injections positions followed a previously 109 published protocol (Supplement 1). 20 110 111
The pain intensity produced by hypertonic saline injections was assessed on a 10 cm electronic visual 112 analogue scale (VAS) which could be adjusted by using an external handheld slider. The VAS was 113 anchored with 'no pain' and 'maximum pain', 0 cm and 10 cm, respectively. A continuous recording 114 (sample frequency of 20 Hz) of the VAS signal was made after each injection until all pain had 115 subsided. For analysis, the area under VAS-time curve (VAS area) and VAS-peak were extracted. 116
117
The quality of pain was assessed once the pain had subsided. Participants were allowed to answer 118 using either the Danish 21 or English 22 version of the McGill Pain Questionnaire based upon their 119 language preference. The Danish results were converted to the English equivalent for analysis. 120
Participants were asked to mark their pain distribution by filling in a standard body chart. Body areas 121
were divided into groin regions by using the "Groin Triangle". 23 The groin triangle is defined as the 122 triangle created by the three landmarks: the anterior superior iliac spine (ASIS), pubic tubercle and the 123 median point between the ASIS and the superior pole of the patella in the anterior coronal plane ('3G 124 point'). 24 Local pain was defined as pain experienced only at the injection site and related "Groin 125 measurement was recorded three times at baseline with two measurements recorded during pain and 135 post-pain to ensure all testing could be completed within the short-lasting window of saline-induced 136 pain. The average of the measurements was used for statistical analysis. PPT measurement was ceased 137 at 1200 kPa to avoid sensitisation after repeated assessments. 138
139
A battery of six pain provocation tests (Supplement 2) was employed with all tests performed by a 140 single clinically-trained experimenter (MD). All participants were confirmed to be pain-free on all 141 tests prior commencing the study. The tests administered were as previously published: 20 1) Bilateral 142 adduction (squeeze) test with hips at 0° resisted at the ankles 25 2) A bilateral squeeze test 11 with hips 143 flexed at 45° 3) A bilateral squeeze test 11 with hips flexed to 90°4) Resisted abdominal crunch 25 5) 144
Resisted oblique crunch, one side at a time. 25 The force of contraction was measured using a hand-145 held dynamometer (MicroFET2, Hoggan Health Industries, USA) at baseline, during-pain and post-146 pain. The reliability of the 0° adduction test is high (ICC = 0.97, minimal detectable change (%) = 147 6.6). 26 Verbal encouragement by the assessor was given to ensure force output remained constant for 148 each repetition (within 10% of baseline measures). 149
150
The skin at each assessment site was shaved, abraded and cleaned with alcohol in accordance with the 151 SENIAM guidelines. 27 Disposable electrodes (Ambu®, Neuroline 720, Denmark) were mounted 152 bilaterally with an inter-electrode distance of 20 mm in a bipolar configuration at the m. tensor fascia 153 latae (TFL), the m. adductor longus (AL), m. rectus abdominis (RA), and m. external obliques (EO). 11, 154 28 A ground electrode was placed on the right wrist. The EMG signal from the AL muscle was used as 155 reference to determine the time window for the amplitude analysis (from onset to offset) 29 where the 156 root-mean-square (RMS) value was extracted for all muscles during all six tests for the middle epoch 157 defined as middle third of the period between onset and offset (see Supplement 1 for extended 158 methodology). The RMS value represents the muscle activity of the muscle. The onsets and offsets 159 were automatically detected based on the AL muscle EMG data as previously described in detail by Page 7 of 17 manual correction of the data was required. Onsets and offsets were not analysed as the research 162 question investigated related to maximal muscle activity pre-, during and post-experimental pain 163 conditions rather than changes in the order of activation as a result of pain. Filtered EMG data was 164 utilised for analysis however filter and normalised data to baseline measures is reported in the 165 supplements for the ease of interpretation clinically. 166
167
All data was assessed for normality using the Kolmogorov-Smirnov test. Means and standard 168 deviations (SD) are presented for parametric data. All statistical analyses were performed using Stata 169 13 IC unless indicated (StataCorp, USA). An a priori estimate of group size indicated 15 participants 170 were required (estimated 20% difference in effect parameters; α=5%; β=20%; coefficient of 171 variance=25%). The VAS area was analysed with an analysis of variance (ANOVA) with muscle (AL 172 and RF) and injection (hypertonic and isotonic) as independent factors. To assess the relationship of 173 Results 187
The VAS area after hypertonic saline injected into the AL (13112 ± 11147 mm·s) and RF (12110 ± 188 8829 mm·s) tendons were higher compared with isotonic saline (AL: 206 ± 405 mm·s; RF: 815 ± 189 2037 mm·s; ANOVA: F(2,53)=20.05, p<0.001). The VAS-peaks reported for each test condition 190 were AL isotonic (2 ± 4mm), AL hypertonic (22 ± 12 mm), RF isotonic (4 ± 7 mm), and RF 191 hypertonic (22 ± 12 mm).The three most common words to describe the sensation after the AL tendon 192 hypertonic injections were "annoying" (33% of participants), "tugging" (27%) and "pressing" (27%) 193
whereas the three most common descriptions after the RF tendon hypertonic injections "tight" (47%), 194 "pressing" (33%), "annoying" (27%) for RF tendon. groin injuries, palpation (mechanical sensitivity) has the greatest diagnostic capacity to predict MRI 260 findings. 33 In the present study, no changes were observed at the site of the injection or on the pubic 261 bone PTTs under the AL or RF ipsilateral hypertonic saline-induced pain indicating secondary 262 mechanical hyperalgesia is less of a concern for this site. Therefore, hyperalgesia of the pubic bone 263 may represent local mechanical hyperalgesia rather than regional/widespread pain and as such may be 264 implicated as a nociceptive driver. Clinically, mechanical sensitivity (tenderness on palpation) at the 265 pubic enthesis may represent local nociception rather than a consequence of adductor tendon pain (as 266 in the case of secondary hyperalgesia). Confirmation in the clinical setting is warranted however. 267
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The magnitude of muscle activity in the region during the painful condition was not statistically 269 significantly different from the baseline condition. This is hypothesised to be due to the study design 270 in which force was maintained equal to baseline measures. This indicates that irrespective of pain in 271 the region, the motor cortex may allow for the task to be completed with equal force production. The 272 0° adduction test has been suggested to be diagnostically superior to identify experimentally-induced, This study has shown that pain arising from the adductor longus tendon is locally distributed in the 292 majority (80%) but capable of producing pain superior to the pubic crest in 33% of participants. PPTs 
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Introduction 26
The prevalence of hip and groin pain in athletes is generally high with a career prevalence of 45% 27 reported in professional Australian football players 1 and a high incidence in sports such as football 2 28 and ice hockey. Experimental pain caused by injection of hypertonic saline into tendons in healthy participants has 54 been shown to cause increased trunk muscle activity, 16, 17 large pain referral patterns, 16, 18 regional 55 hyperalgesia, 16, 18, 19 and facilitated response to clinical orthopaedic tests for the hips and pelvic girdle. 56 16, 18, 19 Therefore, a hypertonic saline model may provide insights into the effect of pain in the groin 57 region on the muscle activity, mechanical sensitivity, and referral patterns. 
Methods 67
Fifteen healthy male participants were included for this study (mean ± SD; age, 26.9 ± 3.4 years; 68 height, 183.9 ± 5.4 cm; weight, 81.5 ± 7.1 kg). Inclusion criteria were 1) no current or previous hip, 69 groin, or lumbar region injuries; 2) no signs of neurological disorders or rheumatologic diseases 70 which could affect the outcome of the experimental procedure; 3) no reported medication use either 71 on enrolment or on a regular basis; 4) currently participating in regular exercise or sport of total 72 duration of greater than or equal to 2.5 hours a week. Exclusion criteria were current injury, any 73 history of pain or injury in the hip, groin, lower abdominal or lumbar regions, a history of lower limb 74 injury in the previous 2 years, usage of cannabis, opioids or other drugs, current use of pain 75 medication, previous neurologic, musculoskeletal or mental illnesses, or lack of ability to cooperate. 76 Participants were given a detailed verbal and written explanation of the experimental procedure. All 77 participants provided written informed consent. The study was approved by the Danish Regional 78
Ethics Committee (N-20130036) and conducted in accordance with the Helsinki Declaration. injecting sterile hypertonic saline (1 ml, 5.8%) into the adductor longus (AL) tendon with isotonic 98 saline (1 ml, 0.9%) injected as a non-painful control into the same anatomical site on the contralateral 99 side within the same session. As a positive (painful) control injection outside the groin area, the 100 proximal tendon of the long head of the rectus femoris (RF) muscle was injected in a separate session. 101
given over the duration of approximately 10 seconds using a 2-ml plastic syringe with a disposable 105 needle (27G). Pre-defined anatomical landmarks for injection sites for AL and RF tendons were 106 utilised. The location, depth and alignment of all injection sites were confirmed by real time ultrasound (US) imaging (Acuson 128XP10, NativeTM). The AL tendon was identified using a 108 method previously described. 18 Participants were asked to mark their pain distribution by filling in a standard body chart. Body areas 121
were divided into groin regions by using the "Groin Triangle". 23 The groin triangle is defined as the 122 triangle created by the three landmarks: the anterior superior iliac spine (ASIS), pubic tubercle and the 123 median point between the ASIS and the superior pole of the patella in the anterior coronal plane ('3G 124 point'). 24 Local pain was defined as pain experienced only at the injection site and related "Groin 125
Triangle" segment while referred pain was defined as any pain felt outside the segment containing the 126 injection site. The body regions were analysed by registering the frequency of pain experienced in the 127 region for all four injections. 128 129 Pressure pain thresholds (PPTs) were assessed at regional and distant sites using a handheld pressure 130 algometer (Somedic, Sweden) with a 1 cm 2 probe and using a 30 kPa/s ramp. The four bilateral 131 assessment sites were the AL tendon injection site, the RF tendon injection site, the anterior surface of 132 the superior pubic rami (PB), and the tibialis anterior (TA) muscle, measured as the proximal site 1/3 133 the distance from the lateral joint line of the knee to the inferior aspect of the lateral malleolus. Each 134 measurement was recorded three times at baseline with two measurements recorded during pain and 135 post-pain to ensure all testing could be completed within the short-lasting window of saline-induced 136 pain. The average of the measurements was used for statistical analysis. PPT measurement was ceased 137 at 1200 kPa to avoid sensitisation after repeated assessments. 138
139
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The magnitude of muscle activity in the region during the painful condition was not statistically 269 significantly different from the baseline condition. This is hypothesised to be due to the study design 270 in which force was maintained equal to baseline measures. This indicates that irrespective of pain in 271 the region, the motor cortex may allow for the task to be completed with equal force production. The 272 0° adduction test has been suggested to be diagnostically superior to identify experimentally-induced, 273
adductor-related pain. 20 However, the results of this paper indicate that changes in muscle activation 274 less likely to be associated with the diagnostic capabilities reported. Again, this hypothesis should be 275 tested in clinical populations. 276
277
This study allowed the evaluation of the outcome measures under controlled conditions. This removes 278 the complications of multiple pathologies detected on clinical assessment 5 and imaging 8 in athletes 279 with groin pain. Nonetheless, pain generated from experimental models differs from clinical pain 18 280 and replication of the results in clinical populations is warranted as previously indicated. In the 281 analysis of PPT and EMG data, a unified linear mixed model was chosen given it ability to account 282 for the characteristics of the data and to reduce the Type I error associated with multiple sub-grouping 283 analyses. The lack of positive findings observed may be potentially explained by lower power 284 however this is offset by the degrees of freedom created by every participant undertaking each 285 component of the study. Significant variability in the data was observed in the PPT and the level of 286 pain (VAS) measures across participants. This variability reduced the ability to obtain significant 287 effects; an increase in sample size is unlikely to alter the results and are likely to represent the 288 individual nature of the response to pain. Post-hoc power analyses are therefore not indicated. 34 289 290
Conclusion 291
This study has shown that pain arising from the adductor longus tendon is locally distributed in the 292 majority (80%) but capable of producing pain superior to the pubic crest in 33% of participants. PPTs 
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